Barnaby Balmforth News Today

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world,...

Genomic tech company Biofidelity, which has operations in Cambridge and North Carolina commercialising precision medicine for patients worldwide, has raised $24 million growth capital.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Cambridge Cluster Life Sciences companies continue to grow stronger and more globally influential and have the opportunity to demonstrate their turnkey excellence in the 2023-24 Business Weekly Awards.

/PRNewswire/ -- Biofidelity today announced the commercial launch of its ASPYRE®-Lung RUO reagent product....

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world,...

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company, has expanded its Board of Directors to include Matt Franklin, MBA, who will join as a...

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company, has developed a low-cost, simple and rapid assay for single-molecule detection of...

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to unleashing the potential of genomics to transform human health and the...

$23 million in new funding will help beef up British cancer diagnostics startup Biofidelity’s U.S. headquarters activity in RTP as it prepares to launch its first commercial product.